Can PBM Support Brain Health? Understanding the Emerging Evidence

Reviewed by: Pediatric Therapists at The Speech Clinic Dubai

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice or a formal treatment recommendation. Photobiomodulation is an emerging investigational and adjunctive modality and should always be discussed with qualified healthcare professionals as part of a comprehensive care plan.

In recent years, transcranial photobiomodulation (tPBM) has attracted growing research interest as a non-invasive approach being investigated for its potential effects on brain function. While light-based therapies have been used in physical therapy and wound healing for decades, studying light energy delivered transcranially (through the skull) to target neural tissue represents an evolving frontier in neurorehabilitation research.

So, what does current science actually say about PBM and brain health? Can light energy influence cognitive, motor, or neurological function, and where does it fit within evidence-based clinical practice?

In This Article

• What is Photobiomodulation (PBM)?
• How May Light Energy Affect Neural Tissue?
• What Does Current Clinical Evidence Show?
• What PBM Cannot Tell Us Yet
• Potential Applications in Pediatric and Neurodevelopmental Research
• Understanding PBM as a Complementary Modality
• Frequently Asked Questions
• Integrative Care at The Speech Clinic Dubai
• What Parents and Patients Should Take Away
• References

What is Photobiomodulation (PBM)?

Photobiomodulation (PBM) is a non-invasive light-based modality that uses specific wavelengths of red or near-infrared light to influence biological processes. While PBM has been studied in several areas of rehabilitation and clinical research, its application to brain-related conditions, particularly in pediatric and neurodevelopmental populations, remains an active area of investigation.

Unlike surgical lasers or high-heat therapeutic devices, PBM uses low-intensity Light Emitting Diodes (LEDs) or low-level lasers. Depending on the wavelength, device parameters, and treatment site, a portion of near-infrared light may penetrate superficial tissues and the skull, which is why transcranial PBM is being investigated for potential effects on underlying neural tissue.

How May Light Energy Affect Neural Tissue? (Investigated Biological Mechanisms)

To understand how PBM is hypothesized to work, researchers study its interactions with neural and glial cells. Key proposed biological mechanisms under investigation include:

1. Proposed Mitochondrial and ATP Influence

Inside neural cells, tiny organelles called mitochondria generate adenosine triphosphate (ATP), the primary energy currency of the cell. One proposed mechanism involves the interaction of red and near-infrared light with mitochondrial components, including cytochrome c oxidase (CCO). This process has been proposed to influence mitochondrial signaling and cellular energy output.

2. Investigated Effects on Cerebral Circulation

Research suggests that transcranial PBM may influence local blood flow. Scientists hypothesize that light interaction may trigger the release of nitric oxide (NO), a signaling molecule that promotes vasodilation, potentially influencing regional cerebral blood flow and tissue oxygenation.

3. Potential Modulation of Neuroinflammation and Oxidative Pathways

Inflammatory processes and oxidative stress are relevant to many neurological and neurodevelopmental conditions. Laboratory and preliminary clinical studies are investigating whether light stimulation can modulate pro-inflammatory signaling pathways and support cellular antioxidant defenses.

These mechanisms remain active areas of investigation, and demonstrating a biological effect does not automatically establish a meaningful clinical benefit for patients.

What Does Current Clinical Evidence Show?

The scientific community continues to evaluate transcranial PBM through clinical trials, though substantial heterogeneity exists across study designs, device parameters, and patient populations.

How Should These Findings Be Interpreted?

Research findings should be interpreted cautiously because PBM studies differ substantially in wavelength, dose, treatment duration, target area, device design, participant characteristics, and outcome measures. Positive findings from individual trials do not necessarily mean that PBM will produce the same results across different conditions or age groups. Systematic reviews continue to identify promising signals while also highlighting the need for better-standardized protocols and larger controlled studies.

What PBM Cannot Tell Us Yet

Despite growing interest, current research cannot yet answer several important clinical questions with confidence. It is not yet clear which wavelengths, doses, treatment schedules, or brain regions provide the greatest benefit for specific conditions. It is also unclear whether improvements seen in research settings translate into meaningful long-term improvements in everyday communication, learning, motor function, or participation.

For pediatric populations in particular, evidence remains limited. A review of transcranial PBM in neurodevelopmental disorders identified a small number of clinical studies and emphasized the need for larger, randomized, sham-controlled trials.

This means promising findings should be viewed as a reason for further research, not as proof that PBM is an established treatment.

Potential Applications in Pediatric and Neurodevelopmental Research

In pediatric and neurodevelopmental care, transcranial PBM is an emerging area of investigation. Researchers are exploring whether its potential biological effects could complement conventional rehabilitation approaches. However, pediatric evidence remains limited, and PBM should not be presented as an established intervention for improving language, sensory processing, learning, or motor outcomes.

Research in children should not be interpreted in the same way as research in adults. Pediatric brains are developing rapidly, and findings from adult studies cannot automatically be applied to children. Pediatric research therefore requires age-appropriate protocols, safety monitoring, carefully selected outcomes, and adequately controlled clinical trials.

It is also important to note that recent pediatric trials, such as small randomized sham-controlled studies involving children, represent early-stage clinical research. Findings from small cohort studies should not be interpreted as establishing PBM as a standard treatment for autism or other neurodevelopmental conditions.

Current areas of investigation include:

• Potential effects on cellular and neurological processes: Studying how cellular energy and circulation markers respond to light parameters.
• Feasibility and safety of pediatric protocols: Evaluating child-appropriate devices, wearability, and dosage tolerances.
• Possible complementary use alongside structured rehabilitation: Exploring whether adjunctive light delivery during active skill training influences rehabilitation trajectories.
• Further research into appropriate treatment parameters and clinical outcomes: Establishing standardized guidelines for dosage, timing, and patient selection.

To maintain a scientifically grounded perspective, it is helpful to distinguish what the research shows across three levels:

• What is established: PBM has been studied in several areas of rehabilitation and clinical research, while its application to brain-related conditions, particularly pediatric and neurodevelopmental conditions, remains an active area of investigation.
• What is promising: Researchers are actively investigating its potential effects on cellular metabolism, cerebral circulation, cognition, and neurological function.
• What is not established: PBM is not a proven treatment for autism, speech delay, sensory processing difficulties, learning disorders, or other pediatric developmental conditions.

For broader context on PBM in pediatric rehabilitation, read our article on photobiomodulation in pediatric rehabilitation.

Understanding PBM as a Complementary Modality

When evaluating non-invasive neuromodulation techniques, families and clinicians should maintain a clear perspective on clinical roles:

• PBM is NOT a Standalone Therapy: Light exposure alone cannot teach a child functional communication, motor coordination, or social adaptive skills. Skill acquisition requires active behavioral engagement, direct practice, and structured clinical instruction.
• PBM May Be Considered as a Complementary Modality: Researchers are investigating whether PBM could support certain biological processes relevant to rehabilitation. However, evidence is still developing, and PBM should not replace active therapy or be assumed to enhance therapy outcomes without individualized clinical rationale.

Integrative Care at The Speech Clinic Dubai

At The Speech Clinic Dubai, located in Dubai Healthcare City, emerging technologies are considered within the broader context of individualized pediatric rehabilitation. Any adjunctive approach should be evaluated according to the child's clinical needs, available evidence, safety considerations, and established therapeutic goals. PBM, where considered, should complement rather than replace appropriate speech, occupational, physical, or other evidence-informed interventions.

Our multidisciplinary clinical team—spanning speech-language pathology, occupational therapy, and physiotherapy—focuses on comprehensive, individualized functional evaluations. When reviewing emerging adjunctive approaches like Photobiomodulation, we emphasize safety, clinical transparency, and strict adherence to established, active rehabilitation modalities.

What Parents and Patients Should Take Away

As research surrounding Photobiomodulation and brain function continues to evolve, keeping an objective, scientifically grounded perspective is essential:

• The biological mechanisms are actively being studied: Laboratory and clinical research suggests that PBM may influence cellular metabolism, circulation, and signaling pathways, although the precise mechanisms and their clinical significance continue to be investigated.
• Clinical evidence is developing: Early trials show interesting findings in cognitive and cerebral parameters, but large-scale, standardized clinical validation is still ongoing.
• Evidence-based therapy comes first: PBM is not a substitute for active physical, occupational, or speech therapy, but rather an emerging subject of research as a potential adjunctive tool.

If you have questions about developmental evaluations, evidence-based pediatric therapies, or how we construct individualized treatment plans, our clinical team is here to support your family.

• Learn more about our Physical Therapy Services
• Explore our Speech & Language Services
• Reach out to our clinical staff via Contact Us

References

• Hamblin, M. R. (2016). Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical, 6, 113-124.
• Salehpour, F., et al. (2018). Brain Photobiomodulation Therapy: a Narrative Review on Potential Mechanisms and Clinical Applications. Molecular Neurobiology, 55(8), 6601-6636.